Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to evaluate the protective measures and awareness of dentists working in Turkey regarding the COVID-19 pandemic.


Clinical Trial Description

Within the scope of the study, patient care protocols in public and private health institutions during and after the pandemic, published on the website of the Turkish Dental Association (http://www.tdb.org.tr/) A survey consisting of 35 open-ended and multiple-choice questions was prepared based on the updated directive titled. The questions directed to dentists in the prepared questionnaire are distributed as follows: - Demographic information (6 questions), - Physical conditions of the unit to be served (5 questions), - Applications for employees (2 questions), - Applications for appointment and patient admission (4 questions), - Study procedure and treatment protocols (10 questions), - Attitudes towards COVID-19 (8 questions) Existing questionnaire questions were examined by 5 dentists for clarity and finalized. A pilot study was conducted on a group of 20 dentists before the prepared questionnaire started to work. The reliability of the questionnaire was evaluated by retesting this group of 20 people 10 days later. 20 people included in the pilot study were evaluated within the scope of the study. Survey questions were shared online. According to the data of the Turkish Dental Association, survey questions were sent to the registered dentists in the chambers. Before the survey questions appear on the screen, individuals will be informed of the privacy policy for data collection and consent to volunteering is asked. If they answered "no" to the survey, the survey was closed automatically. A second reminder email was sent to those who did not respond to the questionnaire four days later. A reminder e-mail was sent to those who did not respond to the questionnaire, six days after the start date. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05175820
Study type Observational
Source Istanbul University
Contact
Status Completed
Phase
Start date September 21, 2020
Completion date November 5, 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Active, not recruiting NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure